Table 3

Overall proportion of patients who met the quality-of-care indicators

IndicatorNo. (%) of patients*
n = 343
Cases detected by screening13 (3.8)
Adequate colon evaluation324 (94.5)
Preoperative liver imaging313 (91.2)
Preoperative pelvis imaging in patients with rectal cancer (n = 95)91 (95.8)
Patients with rectal cancer who received NEORT (n = 75)47 (62.7)
Patients with rectal cancer who received NEOCT (n = 75)45 (60.0)
Completeness of operative report, mean score ± SD4.04 ± 2.9
Completeness of pathology report
 Reported no. of lymph nodes examined322 (93.9)
 Reported ≥ 12 lymph nodes examined (n = 322)265 (82.3)
 Reported positive lymph nodes (n = 322)115 (35.7)
 No. of lymph nodes collected, mean ± SD18.3 ± 10.0
 Reported quantitative distal margin status271 (79.0)
Reported quantitative circumferential margin status36 (10.5)
Reported distal margin ≥ 1 cm in patients with rectal cancer (n = 68)66 (97.0)
Anastomotic leak in patients with rectal cancer (n = 95)5 (5.3)
In-hospital/30-d mortality11 (3.2)
Local recurrence
Within 2 yr after surgery for rectal cancer and colon cancer23 (6.7)
 Following rectal cancer7 (7.4)
Surveillance colonoscopy within 1 yr after surgery (n = 260)154 (59.2)
  • NEOCT = neoadjuvant chemotherapy; NEORT = neoadjuvant radiotherapy; SD = standard deviation.

  • * Except where noted otherwise.

  • Maximum possible score: 10.